Abstract
32P-postlabeling analysis is an ultrasensitive method for the detection and quantitation of carcinogen–DNA adducts. It consists of four principal steps: (i) enzymatic digestion of DNA to nucleoside 3′-monophosphates; (ii) enrichment of the adduct fraction of the DNA digest; (iii) 5′-labeling of the adducts by transfer of 32P-orthophosphate from [γ-32P]ATP mediated by polynucleotide kinase (PNK); (iv) chromatographic or electrophoretic separation of the labeled adducts or modified nucleotides and quantitation by measurement of their radioactive decay. The assay requires only microgram quantities of DNA and is capable of detecting adducts at frequencies as low as 1 in 1010 nt, making it applicable to the detection of events resulting from environmental exposures, or experiments using physiological concentrations of agents. It has a wide range of applications in human, animal and in vitro studies, and can be used for a wide variety of classes of compound and for the detection of adducts formed by complex mixtures. This protocol can be completed in 3 d.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
17 January 2008
In Figure 1 of the version of this article originally published, the arrow between “*pXp” and “*pX” should not have been bold, as it does not indicate a procedure for which a protocol is given in the article. In addition, the legend should have contained, as the third sentence, the following information: “For procedures leading to *pX as the final products, see Table 2, column 3.” The errors have been corrected in the HTML and PDF versions of the article.
References
Phillips, D.H. et al. Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ. Mol. Mutagen. 35, 222–233 (2000).
Phillips, D.H. DNA adducts as markers of exposure and risk. Mutat. Res. 577, 284–292 (2005).
Poirier, M.C., Santella, R.M. & Weston, A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21, 353–359 (2000).
Phillips, D.H. The formation of DNA adducts. in The Cancer Handbook Vol. 1 (ed. Allison, M.R.) 338–350 (Wiley, Chichester, 2007).
Arlt, V.M., Frei, E. & Schmeiser, H.H. ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29-30 September 2006. Mutagenesis 22, 83–88 (2007).
Gupta, R.C., Reddy, M.V. & Randerath, K. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3, 1081–1092 (1982).
Randerath, K. & Randerath, E. Postlabelling methods—an historical review. in Postlabelling Methods for Detection of DNA Adducts (eds. Phillips, D.H., Castegnaro, M. & Bartsch, H.) 3–9 (International Agency for Research on Cancer, Lyon, 1993).
Poirier, M.C. Chemical-induced DNA damage and human cancer risk. Nat. Rev. Cancer 4, 630–637 (2004).
Phillips, D.H. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23, 1979–2004 (2002).
Pfau, W. & Phillips, D.H. Improved reversed-phase high-performance liquid chromatographic separation of 32P-labelled nucleoside 3′,5′-bisphosphate adducts of polycyclic hydrocarbons. J. Chromatogr. 570, 65–76 (1991).
Phillips, D.H. et al. N-Demethylation accompanies α-hydroxylation in the metabolic activation of tamoxifen in rat liver cells. Carcinogenesis 20, 2003–2009 (1999).
Osborne, M.R. et al. Synthesis, characterization, and 32p-postlabeling analysis of DNA adducts derived from the environmental contaminant 3-nitrobenzanthrone. Chem. Res. Toxicol. 18, 1056–1070 (2005).
Arlt, V.M. et al. Identification of three major DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in rat lung at the C8 and N2 position of guanine and at the N6 position of adenine. Int. J. Cancer 118, 2139–2146 (2006).
Phillips, D.H. & Castegnaro, M. Results of an interlaboratory trial of 32P-postlabelling. in Postlabelling Methods for Detection of DNA Damage (eds. Phillips, D.H., Castegnaro, M. & Bartsch, H.) 35–49 (IARC, Lyon, 1993).
Phillips, D.H. & Castegnaro, M. Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 14, 301–315 (1999).
Osborne, M.R. & Phillips, D.H. Preparation of a methylated DNA standard, and its stability on storage. Chem. Res. Toxicol. 13, 257–261 (2000).
Vodicka, P. & Hemminki, K. 32P-Postlabeling of N-7, N2 and O6 2′-deoxyguanosine 3′-monophosphate adducts of styrene oxide. Chem. Biol. Interact. 77, 39–50 (1991).
Beland, F.A. et al. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem. Res. Toxicol. 12, 68–77 (1999).
Haack, T. et al. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3′-phosphate adducts. Chem. Res. Toxicol. 17, 776–784 (2004).
Harvey, J.S., Lyons, B.P., Waldock, M. & Parry, J.M. The application of the 32P-postlabelling assay to aquatic biomonitoring. Mutat. Res. 378, 77–88 (1997).
Brown, K., Heydon, R.T., Jukes, R., White, I.N. & Martin, E.A. Further characterisation of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N,N-didesmethyltamoxifen. Carcinogenesis 20, 2011–2016 (1999).
Arlt, V.M. et al. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis, doi:10.1093/carcin/bgm079 (2007).
Arlt, V.M. 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence. Mutagenesis 20, 399–410 (2005).
Arlt, V.M. et al. Environmental pollutant and potent mutagen 3-nitrobenzanthrone forms DNA adducts after reduction by NAD(P)H:quinone oxidoreductase and conjugation by acetyltransferases and sulfotransferases in human hepatic cytosols. Cancer Res. 65, 2644–2652 (2005).
Podmore, K., Farmer, P.B., Herbert, K.E., Jones, G.D. & Martin, E.A. 32P-postlabelling approaches for the detection of 8-oxo-2′-deoxyguanosine-3′-monophosphate in DNA. Mutat. Res. 378, 139–149 (1997).
Wilson, V.L., Taffe, B.G., Shields, P.G., Povey, A.C. & Harris, C.C. Detection and quantification of 8-hydroxydeoxyguanosine adducts in peripheral blood of people exposed to ionising radiation. Environ. Health Perspect. 99, 261–263 (1993).
Devanaboyina, U. & Gupta, R.C. Sensitive detection of 8-hydroxy-2'-deoxyguanosine in DNA by 32P-postlabeling assay and the basal levels in rat tissues. Carcinogenesis 17, 917–924 (1996).
Weinfeld, M. et al. Use of a postlabelling assay to examine the removal of radiation-induced DNA lesions by purified enzymes and human cell extracts. Mutat. Res. 378, 127–137 (1997).
Weinfeld, M., Liuzzi, M. & Paterson, M.C. Response of phage T4 polynucleotide kinase toward dinucleotides containing apurinic sites: design of a 32P-postlabeling assay for apurinic sites in DNA. Biochemistry 29, 1737–1743 (1990).
Weinfeld, M., Liuzzi, M. & Paterson, M.C. Enzymatic analysis of isomeric trithymidylates containing ultraviolet light-induced cyclobutane pyrimidine dimers. II. Phosphorylation by T4 polynucleotide kinase. J. Biol. Chem. 264, 6364–6370 (1989).
Kotova, N., Hemminki, K. & Segerback, D. Urinary thymidine dimer as a marker of total body burden of UV-inflicted DNA damage in humans. Cancer Epidemiol. Biomarkers Prev. 14, 2868–2872 (2005).
Hegi, M.E., Sagelsdorff, P. & Lutz, W.K. Detection by 32P-postlabeling of thymine glycol in γ-irradiated DNA. Carcinogenesis 10, 43–47 (1989).
Reddy, M.V., Bleicher, W.T. & Blackburn, G.R. 32P-Postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase. Cancer Commun. 3, 109–117 (1991).
Weinfeld, M. & Soderlind, K.J. 32P-postlabeling detection of radiation-induced DNA damage: identification and estimation of thymine glycols and phosphoglycolate termini. Biochemistry, 30, 1091–1097 (1991).
Lloyd, D.R. & Hanawalt, P.C. p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res. 60, 517–521 (2000).
Blommaert, F.A. & Saris, C.P. Detection of platinum-DNA adducts by 32P-postlabelling. Nucleic Acids Res. 23, 1300–1306 (1995).
Welters, M.J. et al. Improved 32P-postlabelling assay for the quantitation of the major platinum-DNA adducts. Carcinogenesis 18, 1767–1774 (1997).
Baird, W.M. et al. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak ß-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography. in Postlabelling Methods for Detection of DNA Adducts (eds. Phillips, D.H., Castegnaro, M. & Bartsch, H.) 217–227 (IARC, Lyon, 1993).
Gupta, R.C. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res. 45, 5656–5662 (1985).
Reddy, M.V. & Randerath, K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7, 1543–1551 (1986).
Phillips, D.H. Macromolecular adducts as biomarkers of human exposure to polycyclic aromatic hydrocarbons. in The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons (ed. Luch, A.) 137–169 (Imperial College Press, London, 2005).
Arif, J.M. et al. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. Chem. Res. Toxicol. 19, 295–299 (2006).
Munnia, A. et al. 32P-post-labelling method improvements for aromatic compound-related molecular epidemiology studies. Mutagenesis, doi:10.1093/mutage/gem030 (2007).
Gupta, R.C. & Earley, K. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis 9, 1687–1693 (1988).
Gallagher, J.E., Jackson, M.A., George, M.H., Lewtas, J. & Robertson, I.G. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment. Cancer Lett. 45, 7–12 (1989).
Möller, L., Zeisig, M. & Vodicka, P. Optimization of an HPLC method for analyses of 32P-postlabeled DNA adducts. Carcinogenesis 14, 1343–1348 (1993).
Nortier, J.L. et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342, 1686–1692 (2000).
Arlt, V.M., Bieler, C.A., Mier, W., Wiessler, M. & Schmeiser, H.H. DNA adduct formation by the ubiquitous environmental contaminant 3-nitrobenzanthrone in rats determined by 32P-postlabeling. Int. J. Cancer 93, 450–454 (2001).
Topinka, J. et al. DNA adduct formation in mammalian cell cultures by polycyclic aromatic hydrocarbons (PAH) and nitro-PAH in coke oven emission extract. Mutat. Res. 419, 91–105 (1998).
Phillips, D.H., Hewer, A. & Grover, P.L. Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. Carcinogenesis 7, 2071–2075 (1986).
Gallagher, J. et al. Formation of DNA adducts in rat lung following chronic inhalation of diesel emissions, carbon black and titanium dioxide particles. Carcinogenesis 15, 1291–1299 (1994).
Landvik, N.E. et al. Effects of nitrated-polycyclic aromatic hydrocarbons and diesel exhaust particle extracts on cell signalling related to apoptosis: possible implications for their mutagenic and carcinogenic effects. Toxicology 231, 159–174 (2007).
Stiborova, M. et al. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures. Carcinogenesis 15, 1187–1192 (1994).
Stiborova, M., Stiborova-Rupertova, M., Borek-Dohalska, L., Wiessler, M. & Frei, E. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans. Chem. Res. Toxicol. 16, 38–47 (2003).
Stone, E.M., Williams, J.A., Grover, P.L., Gusterson, B.A. & Phillips, D.H. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells. Carcinogenesis 19, 873–879 (1998).
Williams, J.A. et al. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 21, 1683–1689 (2000).
Phillips, D.H. et al. Organ specificity of DNA adduct formation by tamoxifen and α-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment. Mutagenesis 20, 297–303 (2005).
Stiborova, M., Frei, E., Schmeiser, H.H. & Wiessler, M. 32P-postlabeling analysis of adducts formed from 1-phenylazo-2-hydroxynaphthalene (Sudan I, Solvent Yellow 14) with DNA and homopolydeoxyribonucleotides. Carcinogenesis 13, 1221–1225 (1992).
Stiborova, M. et al. Identification of a genotoxic mechanism for 2-nitroanisole carcinogenicity and of its carcinogenic potential for humans. Carcinogenesis 25, 833–840 (2004).
Reddy, M.V., Bleicher, W.T., Blackburn, G.R. & Mackerer, C.R. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates. Carcinogenesis 11, 1349–1357 (1990).
Randerath, K., Randerath, E., Danna, T.F., van Golen, K.L. & Putman, K.L. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates. Carcinogenesis 10, 1231–1239 (1989).
Dunn, B.P. & San, R.H. HPLC enrichment of hydrophobic DNA adducts for enhanced sensitivity of 32P-postlabeling analysis. Carcinogenesis 9, 1055–1060 (1988).
Turesky, R.J. & Markovic, J. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline at the C-8 and N2 atoms of guanine. Chem. Res. Toxicol. 7, 752–761 (1994).
Phillips, D.H. et al. Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes. Carcinogenesis 17, 88–94 (1996).
Cooper, D.P., Griffin, K.A. & Povey, A.C. Immunoaffinity purification combined with 32P-postlabelling for the detection of O6-methylguanine in DNA from human tissues. Carcinogenesis 13, 469–475 (1992).
Nair, J., Barbin, A., Guichard, Y. & Bartsch, H. 1,N6-Ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabelling. Carcinogenesis 16, 613–617 (1995).
Gorelick, N.J. & Wogan, G.N. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method. Carcinogenesis 10, 1567–1577 (1989).
Pfau, W., Brockstedt, U., Söhren, K. & Marquardt, H. 32P-Post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis 15, 877–882 (1994).
Terashima, I., Suzuki, N. & Shibutani, S. 32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts. Chem. Res. Toxicol. 15, 305–311 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Phillips, D., Arlt, V. The 32P-postlabeling assay for DNA adducts. Nat Protoc 2, 2772–2781 (2007). https://doi.org/10.1038/nprot.2007.394
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.394
This article is cited by
-
An electrochemical biosensor for T4 polynucleotide kinase activity identification according to host–guest recognition among phosphate pillar[5]arene@palladium nanoparticles@reduced graphene oxide nanocomposite and toluidine blue
Microchimica Acta (2023)
-
Feeding Brassica vegetables to rats leads to the formation of characteristic DNA adducts (from 1-methoxy-3-indolylmethyl glucosinolate) in many tissues
Archives of Toxicology (2022)
-
A label-free T4 polynucleotide kinase fluorescence sensor based on split dimeric G-quadruplex and ligation-induced dimeric G-quadruplex/thioflavin T conformation
Analytical and Bioanalytical Chemistry (2022)
-
Benzo[a]pyrene and Caenorhabditis elegans: defining the genotoxic potential in an organism lacking the classical CYP1A1 pathway
Archives of Toxicology (2021)
-
A DNA functionalized porphyrinic metal-organic framework as a peroxidase mimicking catalyst for amperometric determination of the activity of T4 polynucleotide kinase
Microchimica Acta (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.